News

Chronic rhinosinusitis with nasal polyps increases the likelihood of developing coexisting conditions, such as asthma, ...
Use of a pMDI with a holding chamber is noninferior to nebulization for delivering salbutamol in children with asthma exacerbations.
Patients with severe asthma who initiate biologics may reduce their risk for oral corticosteroids (OCS)-related new-onset adverse outcomes.
Sotatercept-csrk was first approved in 2024 to treat pulmonary arterial hypertension (PAH) in adults based on results seen in the phase 3 STELLAR trial.
Campfires and fireworks are some other triggers this season for anyone with asthma. Health experts say smoke is an asthma trigger -- not to mention the smoke can be unhealthy for anyone’s lungs. The ...
Risk aversion to steroid side effects shaped treatment choices, underscoring support for tailored approaches in managing ...
A study published in July 2025 issue of Journal of Allergy and Clinical Immunology Global highlighted persistent challenges ...
Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) is one of the 13 Best Healthcare Stocks to Buy Under $10. On June 12, Amneal ...